Home LiteratureArticle Details
PMID: 14722309 Published · ppublish English Journal Article

Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Journal of virology ·Vol. 78 ·No. 3 ·2004-02-00 ·Pages 1552-63

Ono A, Freed EO

Abstract

The human immunodeficiency virus type 1 (HIV-1) assembly-and-release pathway begins with the targeting of the Gag precursor to the site of virus assembly. The molecular mechanism by which Gag is targeted to the appropriate subcellular location remains poorly understood. Based on the analysis of mutant Gag proteins, we and others have previously demonstrated that a highly basic patch in the matrix (MA) domain of Gag is a major determinant of Gag transport to the plasma membrane. In this study, we determined that in HeLa and T cells, the MA mutant Gag proteins that are defective in plasma membrane targeting form virus particles in a CD63-positive compartment, defined as the late endosome or multivesicular body (MVB). Interestingly, we find that in primary human macrophages, both wild-type (WT) and MA mutant Gag proteins are targeted specifically to the MVB. Despite the fact that particle assembly in macrophages occurs at an intracellular site rather than at the plasma membrane, we observe that WT Gag expressed in this cell type is released as extracellular virions with high efficiency. These results demonstrate that Gag targeting to and assembly in the MVB are physiologically important steps in HIV-1 virus particle production in macrophages and that particle release in this cell type may follow an exosomal pathway. To determine whether Gag targeting to the MVB is the result of an interaction between the late domain in p6(Gag) and the MVB sorting machinery (e.g., TSG101), we examined the targeting and assembly of Gag mutants lacking p6. Significantly, the MVB localization of Gag was still observed in the absence of p6, suggesting that an interaction between Gag and TSG101 is not required for Gag targeting to the MVB. These data are consistent with a model for Gag targeting that postulates two different cellular binding partners for Gag, one on the plasma membrane and the other in the MVB.

MeSH Terms
Antigens, CD/metabolism Cell Membrane/metabolism,virology Cells, Cultured Endosomes/metabolism,virology Gene Products, gag/chemistry,genetics,metabolism HIV-1/metabolism,pathogenicity HeLa Cells/virology Humans Jurkat Cells/virology Macrophages/virology Monocytes/virology Mutation Organ Specificity Phosphoproteins/genetics Platelet Membrane Glycoproteins/metabolism Tetraspanin 30 Viral Matrix Proteins/genetics Virion/metabolism Virus Assembly/physiology
Chemicals
Antigens, CD CD63 protein, human Gene Products, gag MA protein, Rous sarcoma virus Phosphoproteins Platelet Membrane Glycoproteins Tetraspanin 30 Viral Matrix Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ono Akira
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0460, USA. [email protected]
Freed Eric O
References (61)
61 references, click to expand
  1. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking.
    Traffic. 2000 Mar;1(3):248-58 PMID: 11208108
  2. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
    J Virol. 1995 Mar;69(3):1984-9 PMID: 7853546
  3. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.
    Cell. 2001 Oct 5;107(1):55-65 PMID: 11595185
  4. Plasma membrane rafts play a critical role in HIV-1 assembly and release.
    Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13925-30 PMID: 11717449
  5. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
    Nat Med. 2001 Dec;7(12):1313-9 PMID: 11726971
  6. Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane.
    Biochim Biophys Acta. 2001 Oct 31;1533(3):190-206 PMID: 11731330
  7. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    J Virol. 2002 Jan;76(1):105-17 PMID: 11739676
  8. Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells.
    J Virol. 2002 Jan;76(1):436-43 PMID: 11739711
  9. Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells.
    Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15239-44 PMID: 11742097
  10. VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment.
    J Virol. 2002 Feb;76(4):1825-38 PMID: 11799178
  11. The protein tyrosine kinase Hck is located on lysosomal vesicles that are physically and functionally distinct from CD63-positive lysosomes in human macrophages.
    J Cell Sci. 2002 Jan 1;115(Pt 1):81-9 PMID: 11801726
  12. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
    Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60 PMID: 11805336
  13. Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes.
    Traffic. 2002 Mar;3(3):218-32 PMID: 11886592
  14. Viral late domains.
    J Virol. 2002 May;76(10):4679-87 PMID: 11967285
  15. The biogenesis and functions of exosomes.
    Traffic. 2002 May;3(5):321-30 PMID: 11967126
  16. Phosphoinositides and signal transduction.
    Cell Mol Life Sci. 2002 May;59(5):761-79 PMID: 12088277
  17. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3099-104 PMID: 8610175
  18. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
    J Virol. 1996 Dec;70(12):8540-8 PMID: 8970978
  19. Role of the small GTPase Rab7 in the late endocytic pathway.
    J Biol Chem. 1997 Feb 14;272(7):4391-7 PMID: 9020161
  20. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
    J Virol. 1997 Jun;71(6):4409-18 PMID: 9151831
  21. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport.
    J Virol. 1997 Jul;71(7):5549-59 PMID: 9188629
  22. Identification of an early endosomal protein regulated by phosphatidylinositol 3-kinase.
    Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7326-30 PMID: 9207090
  23. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
    J Virol. 1997 Aug;71(8):5841-8 PMID: 9223473
  24. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function.
    Nature. 1998 Mar 12;392(6672):193-7 PMID: 9515966
  25. Efficient HIV-1 replication can occur in the absence of the viral matrix protein.
    EMBO J. 1998 May 1;17(9):2699-708 PMID: 9564051
  26. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes.
    J Biol Chem. 1998 Aug 7;273(32):20121-7 PMID: 9685355
  27. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.
    J Virol. 1998 Oct;72(10):7950-9 PMID: 9733833
  28. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Virology. 1998 Nov 10;251(1):1-15 PMID: 9813197
  29. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    J Virol. 2000 Mar;74(6):2855-66 PMID: 10684302
  30. A block to human immunodeficiency virus type 1 assembly in murine cells.
    J Virol. 2000 Apr;74(8):3859-70 PMID: 10729160
  31. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.
    J Virol. 2000 Sep;74(18):8670-9 PMID: 10954568
  32. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.
    Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62 PMID: 11087859
  33. Human macrophages accumulate HIV-1 particles in MHC II compartments.
    Traffic. 2002 Oct;3(10):718-29 PMID: 12230470
  34. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding.
    Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13037-42 PMID: 12244217
  35. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection.
    Curr Med Chem. 2002 Nov;9(21):1893-903 PMID: 12369874
  36. Receptor downregulation and multivesicular-body sorting.
    Nat Rev Mol Cell Biol. 2002 Dec;3(12):893-905 PMID: 12461556
  37. Specificity of plasma membrane targeting by the rous sarcoma virus gag protein.
    J Virol. 2003 Jan;77(1):470-80 PMID: 12477852
  38. Mechanisms of enveloped RNA virus budding.
    Trends Cell Biol. 2002 Dec;12(12):569-79 PMID: 12495845
  39. Infectious HIV-1 assembles in late endosomes in primary macrophages.
    J Cell Biol. 2003 Aug 4;162(3):443-55 PMID: 12885763
  40. The role of mononuclear phagocytes in HTLV-III/LAV infection.
    Science. 1986 Jul 11;233(4760):215-9 PMID: 3014648
  41. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.
    Science. 1986 Sep 5;233(4768):1089-93 PMID: 3016903
  42. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.
    J Virol. 1988 Aug;62(8):2578-86 PMID: 3260631
  43. Morphogenesis and morphology of HIV. Structure-function relations.
    Arch Virol. 1989;106(1-2):1-13 PMID: 2669684
  44. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types.
    J Exp Med. 1989 Oct 1;170(4):1149-63 PMID: 2571666
  45. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.
    Annu Rev Immunol. 1990;8:169-94 PMID: 2188662
  46. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments.
    Cell. 1990 Jul 27;62(2):317-29 PMID: 2115402
  47. Transport and assembly of gag proteins into Moloney murine leukemia virus.
    J Virol. 1990 Nov;64(11):5306-16 PMID: 1698996
  48. Assembly and morphology of HIV: potential effect of structure on viral function.
    AIDS. 1991 Jun;5(6):617-37 PMID: 1652977
  49. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):70-4 PMID: 1729720
  50. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum.
    J Virol. 1993 Aug;67(8):4972-80 PMID: 8331736
  51. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor.
    J Virol. 1993 Nov;67(11):6387-94 PMID: 8411340
  52. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
    J Virol. 1995 Jun;69(6):3949-54 PMID: 7745752
  53. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    J Virol. 1995 Nov;69(11):6810-8 PMID: 7474093
  54. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes.
    J Virol. 1995 Dec;69(12):7699-711 PMID: 7494279
  55. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
    J Virol. 1994 Apr;68(4):2503-12 PMID: 8139032
  56. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.
    J Virol. 1994 Aug;68(8):5311-20 PMID: 8035531
  57. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
    J Virol. 1994 Oct;68(10):6644-54 PMID: 7521919
  58. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein.
    Biochem Biophys Res Commun. 1994 Nov 15;204(3):1031-8 PMID: 7980574
  59. Generation of high-titer pseudotyped retroviral vectors with very broad host range.
    Methods Cell Biol. 1994;43 Pt A:99-112 PMID: 7823872
  60. Transport of envelope proteins of Sendai virus, HN and F0, is blocked at different steps by thapsigargin and other perturbants to intracellular Ca2+.
    J Biochem. 1994 Sep;116(3):649-56 PMID: 7852286
  61. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).
    Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 PMID: 11427703
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-02-00
Pages
1552-63
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC321403
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]